Fact CheckerSign in

NCT06764914Not yet recruiting

Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache

NAturheilkundliche Komplextherapie Bei Episodischer MIgräne Und KOpfschmerz Vom Spannungstyp

Source: ClinicalTrials.gov · Last updated 9 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study is a monocentric uncontrolled observational study to evaluate a 12-14 day inpatient stay in an internal medicine clinic for integrative and complementary medicine for patients with episodic migraine and/or episodic tension headache. The aim is to investigate the extent to which a 14-day inpatient stay can influence a reduction in headache days and/or pain intensity, medication use, quality of life, anxiety, depression, perceived stress, general well-being, and a reduction in sick days/work absenteeism, and prevent the chronification of migraine and may counteract the chronification of migraine or tension-type headache. In addition, patients' previous experiences with complementary naturopathic therapies, expectations and perceived benefits in everyday life will be analysed.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
130 (estimated)
First submitted
12 Dec 2024
Start date
1 Jan 2025
Primary completion date
1 Jan 2030
Lead sponsor
Kliniken Essen-Mitte
Diseases
Migraine
NCT number
NCT06764914

What you commit to

  • Study type: Observational
  • Planned participants: 130
  • From 1 Jan 2025 to the primary completion date, 1 Jan 2030
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Medication-induced headache/painkiller abuse (\> 10 triptans/combination analgesics/ergotamines/opiates or \>15 classical analgesics per month)

Other illness

  • Acute severe mental illness (e.g. severe depression with suicidal tendencies)
  • Acute, severe physical illness that prevents participation in the inpatient naturopathic programme or emergency inpatient treatment of a different kind (e.g. ongoing treatment of a cancer severe acute illness of the cardiovascular system such as heart attack, stroke, acute insufficiency of other organs (kidney, liver, etc.), other severe acute neurological diseases, e.g. relapse of multiple sclerosis, uncontrolled epilepsy)

Age

  • Age younger than 18 years

Other

  • Chronic migraine (15 migraine days in the last 3 months) or chronic tension type headache
  • Pregnancy/lactation period
  • Simultaneous participation in other clinical studies
  • No consent

Who the study is looking for

  • Episodic migraine (\<15 headache days/month in the last 3 months)
  • Episodic tension headache (\<15 headache days/month in the last 3 months)
  • Mixed forms or parallel occurrence of both types of headache is permitted
  • Diagnosis confirmed in advance by a neurologist
  • Mandatory imaging to exclude another cause of headache before or during hospitalisation (cMRI or cCT)
  • Participation in the integrative headache supply programm oft the health insurence provider Barmer Ersatzkasse and Techniker Krankenkasse
  • Signed declaration of consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.